Pulmonary EmbolismClot RetractionBlood CoagulationFibrinEmbolism, FatEmbolismFibrinolysisIntracranial EmbolismThrombelastographyEmbolism, ParadoxicalThrombosisTissue Plasminogen ActivatorFibrinogenIntracranial Embolism and ThrombosisEmbolism, Amniotic FluidFactor XIIIaFibrinolytic AgentsBlood Coagulation TestsUltrasonic TherapyHemostaticsPlasminogenHemoglobin Halpha-2-AntiplasminHigh-Intensity Focused Ultrasound AblationThrombolytic TherapyHemostasisBlood Coagulation DisordersFibrinolysinFactor XIIIEmbolism, CholesterolStreptokinaseThrombinVenous ThrombosisCerebral HemorrhageEmbolectomyHeparinAnticoagulantsHemorrhageSubarachnoid HemorrhageVentilation-Perfusion RatioPlasminogen ActivatorsBlood PlateletsPlatelet ActivationBloodTime FactorsVena Cava FiltersThromboembolismRabbitsThrombophlebitisDogsTreatment OutcomeStrokeDisease Models, AnimalRecombinant ProteinsFibrin Clot Lysis TimeEchocardiography, TransesophagealAngiographyTomography, X-Ray ComputedForamen Ovale, PatentAcute DiseaseVenous ThromboembolismVentricular Dysfunction, RightPulmonary ArteryTomography, Spiral ComputedWarfarinThrombectomySwinePhlebographyFemoral VeinHeart Septal Defects, AtrialEmbolism and ThrombosisFibrinogens, AbnormalKineticsHeart DiseasesFatal OutcomeProspective StudiesRisk FactorsRetrospective StudiesPopliteal VeinHeparin, Low-Molecular-WeightCerebral InfarctionRecurrenceIntraoperative ComplicationsNephelometry and TurbidimetryPostoperative ComplicationsIntracranial ThrombosisTechnetium Tc 99m Aggregated AlbuminEchocardiographyXylemVena Cava, InferiorCarboxypeptidase UAntifibrinolytic AgentsIliac VeinAutopsyUrokinase-Type Plasminogen ActivatorFollow-Up StudiesAtrial FibrillationThrombophiliaHeart AtriaPredictive Value of Tests